Hemp analysis at Reference Analytics
In an increasing number of countries, the use of cannabis for medical purposes is being legalized. Europe is expected to become the largest legal cannabis market in the world – with a sales volume of several billion EUR by 2028.
Cannabis has been classified as a medical product by EU authorities, making EudraLex Volume 4 of the „Rules for Medical Devices in the European Union“ – EU GMP for short – applicable.
GMP Certification for Cannabinoid Analytic
GMP certification ensures that drugs are produced in „pharmaceutical quality,“ because end users expect the hemp products they buy to be
do not contain impurities
do not pose any health risks.
Companies that have their products
- tested by third-party laboratories
- publish their certificates of analysis
- produce in compliance with GMP
ensure a significant competitive advantage for themselves.
Reference Analytics offers a broad analytical spectrum to support their clients in this task!
What we offer in hemp analysis
Potency test: Determination of THC content
Profiling: Determination and quantification of the most known cannabinoids such as CBD, CBDA, T-THC, D9THC, THCA, D8THC, T-CBG, CBG, CBGA, CBN, CBC, THCV, CBDV und CBDVA
Mycotoxin determination: determination of aflatoxin
Determination of impurities due to residual solvents, pesticides, heavy metals
Cannabinoid Analtyics Methods
We use our entire methodological portfolio to meet individual requirements in cannabis analysis.
Learn more on residual solvents in cannabis products.
Contact us today!
Reference Analytics is happy to support pharmaceutical companies in the analysis of their hemp products. We will be happy to prepare a suitable offer for you: email@example.com